BS
Brijbhushan Shriniwas Mahajan
About Brijbhushan Shriniwas Mahajan
Data last updated:
Brijbhushan Shriniwas Mahajan is a Designated Partner at Euten Pharma Llp (since 2020). The company operates in Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 15 Dec 2020 | 2019 | Active |
Board colleagues of Brijbhushan Shriniwas Mahajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaykumar Amarchand Chhallani | 08989774 | Euten Pharma Llp | Designated Partner |
| Hardik Piyushkumar Agrawat | 00347694 | Euten Pharma Llp | Designated Partner |
| Manisha Amod Tembhurnikar | 08990265 | Euten Pharma Llp | Designated Partner |
| Mitesh Arjun Valvi | 08460631 | Euten Pharma Llp | Designated Partner |
| Rupali Rahul Gonjari | 08998532 | Euten Pharma Llp | Designated Partner |
| Tanuja Jeevak Ghadage | 08201706 | Euten Pharma Llp | Designated Partner |
| Yogesh Arun Suryawanshi | 08989799 | Euten Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Brijbhushan Shriniwas Mahajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brijbhushan Shriniwas Mahajan
Brijbhushan Shriniwas Mahajan currently holds 1 directorship: Euten Pharma Llp (Designated Partner, since 15 Dec 2020).
Brijbhushan Shriniwas Mahajan was first appointed on 15 Dec 2020 as Designated Partner at Euten Pharma Llp.
The current boards of Brijbhushan Shriniwas Mahajan's companies include Abhaykumar Amarchand Chhallani (Euten Pharma Llp), Hardik Piyushkumar Agrawat (Euten Pharma Llp), Manisha Amod Tembhurnikar (Euten Pharma Llp), Mitesh Arjun Valvi (Euten Pharma Llp), Rupali Rahul Gonjari (Euten Pharma Llp), Tanuja Jeevak Ghadage (Euten Pharma Llp), among others.